Biotechnology the Victorian way - Pharmaceutical Technology Asia Pacific
Apply for Free Subscription now!
Pharm Technology Europe Media Kit
Buyers Guide 2007/08
Get your free listing now!
Biotechnology the Victorian way
The Victorian government has provided strong leadership, investment and support to drive the development of a dynamic and internationally competitive biotechnology sector.


Pharmaceutical Technology Asia Pacific

Pages | 1 | 2 | 3
more

Biotechnology has huge potential to improve our lives and wellbeing — from new treatments for devastating diseases and injuries, to healthier and more nutritious foods; from better ways to manage natural resources, to new materials, fibres and fuels that will help reduce our impact on the environment.



Victoria, the south-east state of Australia, is determined to establish itself as a leader in biotechnology. It aims to drive the transformation of its traditional manufacturing base into a forward-looking, knowledge-based bioeconomy that applies bioscience discoveries and developments to solve global challenges in health, agriculture, industry and environmental sustainability. Already it is on its way to achieving its goals.

Research excellence

In 2006, Melbourne joined London and Boston as one of only three cities in the world with two universities (the University of Melbourne and Monash University) in the global top 20 Times biomedical rankings.1 The excellence of the region's medical research institutes in the fields of cancer, immunology and infectious diseases is recognized and respected around the world. For example:

  • In 2007, the American Association for Cancer Research honoured Professor Don Metcalf from Melbourne's Walter and Eliza Hall Institute with a Lifetime Achievement Award for his ground-breaking discoveries in cancer research and treatment. Metcalf's discoveries, including the colony stimulating factors (factors that enhance white blood cell formation to help fight infection in cancer patients), have transformed patient cancer care worldwide and underpinned the performance of one of the world's most successful biotech leaders — Amgen (USA).
  • Immunology and infectious diseases continue to be a strength of Victoria's medical research community — from Sir Macfarlane Burnet's Clonal Selection Theory, published in 1957, to the research of Professor Mark Smyth, who was awarded the 2007 Charles Rodolphe Brupbacher Prize for his contribution to cancer immune surveillance. Also, Professor Bill Charman from the Victorian College of Pharmacy (Melbourne) won the WHO/Gates Foundation Medicines for Malaria Vaccine 2006 International Drug Discovery Project of the Year for his antimalarial drug candidates that are effective at a single dose.
  • International recognition of the state's strategic global position is also reflected by the selection of Melbourne as one of only four World Health Organization (WHO) Flu Monitoring Centres (the others being Tokyo (Japan), London (UK) and Atlanta (GA, USA)). The Australian Animal Health Laboratory in Geelong is the world's most advanced high containment facility, and is also an international reference centre for new and emerging diseases, including a WHO SARS collaborating centre. Melbourne is also home to Australia's largest biotechnology company, CSL, which manufactures and exports influenza vaccine, and is one of the top ten biotech companies by revenue.2


Key points
With established strengths in medical research — and a juxtaposition of 15 world class research institutes, seven teaching hospitals and nine universities in a concentrated area — Victoria is exceptionally well-placed to translate research discoveries to other sectors of the economy. One example is the work conducted by the Cooperative Research Centre for Innovative Dairy Products and Dr Paul Verma at the Monash Institute of Medical Research. They have developed new techniques for the efficient isolation and maintenance of bovine embryonic stem cells, creating a bovine stem cell line for the first time. This adds to stem cell lines available for the human, the mouse and the monkey, and significantly extends knowledge about cell development and breeding. Also, Professor German Spangenberg, working with the Department of Primary Industries and the Cooperative Research Centre for Molecular Plant Breeding, has developed a low-allergy, high-nutrition pasture grass for cattle. Cattle fed on the grass gain weight faster and produce more milk. The reduced allergenicity will also be a welcome relief to people who suffer from hayfever and asthma.


Pages | 1 | 2 | 3
more

29 August 2008
Search
Asia Pacific Biotech News
Asia Pacific Biotech News
Source: Pharmaceutical Technology Asia Pacific,
Click here